2023 Letters to Health Care Providers

Title	Date
HSV-2 Tests for Genital Herpes Can Produce False Reactive Results - Letter to Clinical Laboratory Staff and Health Care Providers	12/27/2023
Do Not Use Cardinal Health Monoject Syringes with Syringe Pumps and PCA Pumps - Letter to Health Care Providers	11/20/2023
Labeling Updates for BD Mesh Products - Letter to Health Care Providers	11/09/2023
Update: Evaluation of Airborne Chemicals from Neonatal Incubators - Letter to Health Care Providers	01/03/2024
UPDATE: Risk of Device Failures for Getinge’s Maquet/Datascope Cardiosave Intra-Aortic Balloon Pump (IABP) - Letter to Health Care Providers	08/31/2023
Use Alternative Testing Method for the Quidel Cardiovascular Inc. Quidel Triage Cardiac Panel - Letter to Health Care Providers	07/19/2023
UPDATE: Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease Unlikely to Increase Risk of Mortality - Letter to Health Care Providers	07/11/2023
UPDATE: NuVasive Specialized Orthopedics’ Precice Devices - Letter to Health Care Providers	06/28/2023
Oxygenator Devices Used for Extracorporeal Circulation - Letter to Health Care Providers	06/09/2023
Non-sterile, Single-use Pneumatic Tourniquet Cuffs Conservation Strategies - Letter to Health Care Providers	06/05/2023
Illumina Cybersecurity Vulnerability Affecting the Universal Copy Service Software May Present Risks for Patient Results and Customer Networks: Letter to Health Care Providers	04/27/2023
Update: Potential Risk of Exposure to Toxic Compounds When Using Hemodialysis and Peritoneal Dialysis Systems – Letter to Health Care Providers	03/07/2023
Getinge/Maquet Cardiohelp System: Potential Insufficient Packaging Sterility with HLS Set Advanced - Letter to Health Care Providers	03/01/2023
Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration- Letter to Health Care Providers	02/27/2023